Medication Safety in Pediatric InpatientsNCT07254741
Pharmacist Mobile App Intervention in Pediatric Inpatient
A study testing Pharmacist-Led Medication Review in people with Medication Safety in Pediatric Inpatients, run by Beni-Suef University at 1 site in Egypt.
Trial summary
The goal of this study is to learn whether a clinical pharmacist-led medication review, supported by medical mobile applications, can improve the safety and quality of care for hospitalized children. Read more about this study
- Who is it for?
- Ages 2 to 15 years
- Conditions the study is for
- Medication Safety in Pediatric Inpatients
- What is being tested?
- Pharmacist-Led Medication Review
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 2,000 participants
- Where
- 1 siteEgypt
- Study dates
- 12 Mar 2024to 12 Sep 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 2 to 15 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- Age between 2 and 15 years
- Admitted to the pediatric general inpatient ward
- Prescribed three or more medications during the hospital stay
Who cannot join
- Length of hospital stay less than 48 hours
- Admission to the pediatric intensive care unit (PICU)
- Estimated life expectancy less than 24 hours
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Role of Clinical Pharmacy and Mobile Medical Applications in Detection and Minimization of Different Medication Errors in Hospitalized Patients From Adults and Children
The goal of this study is to learn whether a clinical pharmacist-led medication review, supported by medical mobile applications, can improve the safety and quality of care for hospitalized children. The study compares usual care with enhanced pharmacist involvement to understand whether this approach reduces medication-related problems and supports better clinical outcomes.
The main questions this study aims to answer are:
Read more
Does the pharmacist-led review help identify and prevent medication issues in pediatric inpatients?
Can this intervention improve the overall quality of care during hospitalization?
Does the use of mobile medical applications assist pharmacists in making safer medication decisions?
Participants will:
Receive either routine care or routine care plus daily medication review by a clinical pharmacist
Have their medications assessed regularly to identify potential problems
Be followed during their hospital stay to observe clinical outcomes
- Being tested
- Pharmacist-Led Medication Review
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Pharmacist-Led Medication ReviewBehavioural
Daily medication review conducted by a clinical pharmacist using mobile medical applications to identify potential medication-related problems and support safer prescribing decisions for hospitalized pediatric patients.
| Study group | Role | What they receive |
|---|---|---|
| Pharmacist-Led Medication Review | Experimental | Not described Receives: Behavioral: Pharmacist-Led Medication Review |
| Usual Care | No intervention | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
Medication Errors Identified
Number of medication errors detected during routine review of inpatient medication orders, including prescribing, dosing, frequency, and administration-related issues.
Measured: From admission to hospital discharge (an average of 3-7 days)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Nov 2025
- Study start12 Mar 2024
- Primary completion12 Sep 2024
- Study completion12 Sep 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Medication Safety in Pediatric InpatientsStudies of the same condition, open and under way.
- More trials run by Beni-Suef UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 2,000 participants (actual)
Sponsor and investigators
- Lead sponsor
- Beni-Suef University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Sara Mohammed Abd Elhamid Mohammed Tony, Beni-Suef University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07254741
- Sponsor's protocol ID
- (FMBSUREC/03102023/Tony)
- Status last verified
- Nov 2025
- First submitted
- 18 Nov 2025
- Last updated
- 28 Nov 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 28 Nov 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Role of Clinical Pharmacy and Mobile Medical Applications in Detection and Minimization of Different Medication Errors in Hospitalized Patients From Adults and Children
- ClinicalTrials.gov ID
- NCT07254741
- Acronym / sponsor ID
- (FMBSUREC/03102023/Tony)
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 2,000 participants (actual)
- Lead sponsor
- Beni-Suef UniversityUniversity, hospital or other
- Study start
- 12 Mar 2024 (actual)
- Primary completion
- 12 Sep 2024 (actual)
- Study completion
- 12 Sep 2024 (actual)
- First posted
- 28 Nov 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this study is to learn whether a clinical pharmacist-led medication review, supported by medical mobile applications, can improve the safety and quality of care for hospitalized children. The study compares usual care with enhanced pharmacist involvement to understand whether this approach reduces medication-related problems and supports better clinical outcomes.
The main questions this study aims to answer are:
Does the pharmacist-led review help identify and prevent medication issues in pediatric inpatients?
Can this intervention improve the overall quality of care during hospitalization?
Does the use of mobile medical applications assist pharmacists in making safer medication decisions?
Participants will:
Receive either routine care or routine care plus daily medication review by a clinical pharmacist
Have their medications assessed regularly to identify potential problems
Be followed during their hospital stay to observe clinical outcomes
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Pharmacist-Led Medication Review | Experimental | Behavioral: Pharmacist-Led Medication Review |
| Usual Care | No intervention | – |
Who may qualify
- Ages
- 2 to 15 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (3 listed)
- Age between 2 and 15 years
- Admitted to the pediatric general inpatient ward
- Prescribed three or more medications during the hospital stay
Key exclusion criteria (3 listed)
- Length of hospital stay less than 48 hours
- Admission to the pediatric intensive care unit (PICU)
- Estimated life expectancy less than 24 hours
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Pharmacist-Led Medication ReviewDaily medication review conducted by a clinical pharmacist using mobile medical applications to identify potential medication-related problems and support safer prescribing decisions for hospitalized pediatric patients. | Behavioural | Pharmacist-Led Medication Review |
Primary outcome
Medication Errors Identified
Time frame: From admission to hospital discharge (an average of 3-7 days)
Number of medication errors detected during routine review of inpatient medication orders, including prescribing, dosing, frequency, and administration-related issues.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Nov 2025.
- Individual participant dataSharing planned: No
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Pharmacist-Led Medication Review in people with Medication Safety in Pediatric Inpatients, run by Beni-Suef University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 28 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Medication Errors Identified (time frame: From admission to hospital discharge (an average of 3-7 days)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Nov 2025; AzTrials last refreshed its copy on 1 Nov 2026.